Filtered By:
Specialty: Drugs & Pharmacology
Infectious Disease: COVID-19
This page shows you your search results in order of date.
Order by Relevance | Date
Total 161 results found since Jan 2013.
COVID-19 pandemic on coronary artery and cerebrovascular diseases in Southern Spain: interrupted time series analysis
CONCLUSIONS: A decline in AMI and CVD daily hospital admissions during the first and second wave of COVID-19 pandemic was noted. Gender differences were observed, but no clear impact was observed in percutaneous interventions.PMID:37070925 | DOI:10.26355/eurrev_202304_31955
Source: European Review for Medical and Pharmacological Sciences - April 18, 2023 Category: Drugs & Pharmacology Authors: F J Rodr íguez-Cortés J E Jim énez-Hornero J F Alcal á-Diaz R M Mi ñarro-Del Moral J L Romero-Cabrera R Manfredini M A Rodr íguez-Borrego P J L ópez-Soto Source Type: research
Risk of thromboembolic events in non-hospitalized COVID-19 patients: A systematic review
Eur J Pharmacol. 2023 Jan 11:175501. doi: 10.1016/j.ejphar.2023.175501. Online ahead of print.ABSTRACTThe risk of thromboembolism in non-hospitalized COVID-19 patients remains uncertain and was assessed in this review to better weigh benefits vs. risks of prophylactic anticoagulation in this population. A search was performed through three databases: Medline, Embase, and Cochrane Library until 2022. Self-controlled case series, case-control and cohort studies were included, and findings summarized narratively. Meta-analyses for risk of thromboembolism including deep vein thrombosis (DVT), pulmonary embolism (PE), and myoca...
Source: European Journal of Pharmacology - January 14, 2023 Category: Drugs & Pharmacology Authors: Gaelle P Massoud Dana H Hazimeh Ghadir Amin Wissam Mekary Joanne Khabsa Tarek Araji Souha Fares Mathias Mericskay George W Booz Fouad A Zouein Source Type: research
